Jagsonpal Pharmaceuticals Ltd. Company History and Annual Growth Details

1995 - The Company is well poised to venture into new areas of activity which will propel it into achieving its projected goals.

1998 - The company is all set to realise it's laid-out expansion plans and gain substantially, both in sales volume and profits, with its proposed new product introductions, in the year.

1999 - The Company launched/re-launched a few products, which have been well received in the market.

- The Company raised funds to the tune of Rs.5 crores through issue of 5,00,000 16% Non-Convertible Secured Debentures of Rs. 100 each to Life Insurance Corporation of India, General Insurance Corporation of India (GIC) and four subsidiaries of GIC.

- The company is manufacturing off-patent drugs, where the entry barriers are relatively low.

- The company has entered into tie-ups to make a range of anti-oxidants and hormones which are expected to be launched in 1999-2000.

2000 - The Company is having in-house share transfer and related facilities at the Registered office New Delhi. The Company is entering into an agreement with NSDL and CDSL for
dematerialisation.

2004
-Company has issued a bonus shares in the ratio of 3:1.

2011
-The company has recommended a dividend of Rs. 0.50 per equity shares.
2013
-The company has recommended a dividend of Rs. 0.50 per equity shares.
-Mr. Raj Kumar Kapoor has been appointed as Compliance officer cum Company Secretary of the company.

2014
-The company has recommended dividend of Rs. 0.50/- per Equity share.

2024
-The Company has informed regarding Acquisition for signing Business Transfer Agreement for the purchase of India & Bhutan business of Yash Pharma Laboratories Pvt.Ltd.
-The Company Launches MemUp IndiaÂs First Bioidentical Hormone Replacement Therapy in a Single Pill.

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article